company background image
IQV logo

IQVIA Holdings NYSE:IQV Stock Report

Last Price

US$248.84

Market Cap

US$45.0b

7D

4.9%

1Y

18.1%

Updated

28 Feb, 2024

Data

Company Financials +

IQV Stock Overview

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific.

IQV fundamental analysis
Snowflake Score
Valuation4/6
Future Growth2/6
Past Performance4/6
Financial Health1/6
Dividends0/6

IQVIA Holdings Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for IQVIA Holdings
Historical stock prices
Current Share PriceUS$248.84
52 Week HighUS$251.00
52 Week LowUS$167.42
Beta1.48
1 Month Change14.14%
3 Month Change16.23%
1 Year Change18.06%
3 Year Change30.56%
5 Year Change78.78%
Change since IPO490.93%

Recent News & Updates

IQVIA Holdings: Strong Q4 Results Suggest A Bullish 2024

Feb 22

Recent updates

IQVIA Holdings: Strong Q4 Results Suggest A Bullish 2024

Feb 22

Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 29% Discount?

Jan 23
Is IQVIA Holdings Inc. (NYSE:IQV) Trading At A 29% Discount?

Market Participants Recognise IQVIA Holdings Inc.'s (NYSE:IQV) Earnings

Dec 24
Market Participants Recognise IQVIA Holdings Inc.'s (NYSE:IQV) Earnings

We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Dec 08
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Should You Investigate IQVIA Holdings Inc. (NYSE:IQV) At US$205?

Nov 23
Should You Investigate IQVIA Holdings Inc. (NYSE:IQV) At US$205?

IQVIA Q3: TAS Segment Remains The Problem Child

Nov 21

IQVIA: I Would Stay Away Until Debt Issues Are Resolved

Nov 12

Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 32% Undervaluation?

Oct 08
Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 32% Undervaluation?

IQVIA: Stock To Remain Rangebound As I Expect Weak Numbers In The Near Term

Sep 07

Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

Sep 04
Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

Why IQVIA Holdings Inc. (NYSE:IQV) Could Be Worth Watching

Aug 11
Why IQVIA Holdings Inc. (NYSE:IQV) Could Be Worth Watching

IQVIA Holdings Q2: Breaking Ground And Beating Expectations

Aug 03

IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 43% Above Its Share Price

Jun 27
IQVIA Holdings Inc.'s (NYSE:IQV) Intrinsic Value Is Potentially 43% Above Its Share Price

IQVIA Holdings (NYSE:IQV) Has A Pretty Healthy Balance Sheet

Jun 05
IQVIA Holdings (NYSE:IQV) Has A Pretty Healthy Balance Sheet

IQVIA Holdings: A Possible Beat And Raise Scenario In The Works

May 23

What Does IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Indicate?

May 04
What Does IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Indicate?

A Look At The Fair Value Of IQVIA Holdings Inc. (NYSE:IQV)

Mar 19
A Look At The Fair Value Of IQVIA Holdings Inc. (NYSE:IQV)

Does IQVIA Holdings (NYSE:IQV) Have A Healthy Balance Sheet?

Mar 05
Does IQVIA Holdings (NYSE:IQV) Have A Healthy Balance Sheet?

Here's Why We Think IQVIA Holdings (NYSE:IQV) Might Deserve Your Attention Today

Feb 12
Here's Why We Think IQVIA Holdings (NYSE:IQV) Might Deserve Your Attention Today

IQVIA Q4 2022 Earnings Preview

Feb 09

When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Jan 29
When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

IQVIA Holdings: Premium Valuation Is Justified For An Industry Leader

Jan 24

We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Nov 09
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

IQVIA Holdings Sees Digital Opportunities, But Debt Drags Growth

Nov 02

IQVIA Q3 2022 Earnings Preview

Oct 25

Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

Oct 02
Is Now The Time To Look At Buying IQVIA Holdings Inc. (NYSE:IQV)?

IQVIA: Rebound Is Likely But Downtrend Is Still Intact (Technical Analysis)

Sep 19

With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

Aug 22
With EPS Growth And More, IQVIA Holdings (NYSE:IQV) Makes An Interesting Case

GSK, Iqvia launch Vaccine Track platform to highlight vaccine trends publicly in US

Aug 11

We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

Aug 08
We Think IQVIA Holdings (NYSE:IQV) Can Stay On Top Of Its Debt

IQVIA: Resiliency And Quality Never Left, Q2 Earnings Evidence The Same

Jul 28

Are Investors Undervaluing IQVIA Holdings Inc. (NYSE:IQV) By 48%?

Jul 26
Are Investors Undervaluing IQVIA Holdings Inc. (NYSE:IQV) By 48%?

IQVIA Non-GAAP EPS of $2.44 beats by $0.06, revenue of $3.54B beats by $50M, raises FY22 guidance

Jul 21

IQVIA A Smart Choice In A High-Inflation Environment

Apr 29

When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Mar 28
When Should You Buy IQVIA Holdings Inc. (NYSE:IQV)?

Here's Why We Think IQVIA Holdings (NYSE:IQV) Is Well Worth Watching

Mar 01
Here's Why We Think IQVIA Holdings (NYSE:IQV) Is Well Worth Watching

IQVIA: Intelligent Healthcare Solutions For A Growing Market

Feb 19

IQVIA Holdings (NYSE:IQV) Seems To Use Debt Quite Sensibly

Feb 17
IQVIA Holdings (NYSE:IQV) Seems To Use Debt Quite Sensibly

Is Now An Opportune Moment To Examine IQVIA Holdings Inc. (NYSE:IQV)?

Dec 16
Is Now An Opportune Moment To Examine IQVIA Holdings Inc. (NYSE:IQV)?

Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 33% Undervaluation?

Dec 01
Is There An Opportunity With IQVIA Holdings Inc.'s (NYSE:IQV) 33% Undervaluation?

Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

Oct 17
Is IQVIA Holdings (NYSE:IQV) A Risky Investment?

What Does IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Indicate?

Sep 17
What Does IQVIA Holdings Inc.'s (NYSE:IQV) Share Price Indicate?

A Look At The Fair Value Of IQVIA Holdings Inc. (NYSE:IQV)

Aug 30
A Look At The Fair Value Of IQVIA Holdings Inc. (NYSE:IQV)

Shareholder Returns

IQVUS Life SciencesUS Market
7D4.9%2.4%2.1%
1Y18.1%4.0%26.0%

Return vs Industry: IQV exceeded the US Life Sciences industry which returned 2.7% over the past year.

Return vs Market: IQV underperformed the US Market which returned 25.1% over the past year.

Price Volatility

Is IQV's price volatile compared to industry and market?
IQV volatility
IQV Average Weekly Movement5.0%
Life Sciences Industry Average Movement7.4%
Market Average Movement6.1%
10% most volatile stocks in US Market16.8%
10% least volatile stocks in US Market3.1%

Stable Share Price: IQV has not had significant price volatility in the past 3 months.

Volatility Over Time: IQV's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a87,000Ari Bousbibhttps://www.iqvia.com

IQVIA Holdings Inc. engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment offers a range of cloud-based applications and related implementation services; real world solutions that enable life sciences and provider customers to generate and disseminate evidence, which informs health care decision making and improves patients’ outcomes; and strategic and implementation consulting services, such as advanced analytics and commercial processes outsourcing services.

IQVIA Holdings Inc. Fundamentals Summary

How do IQVIA Holdings's earnings and revenue compare to its market cap?
IQV fundamental statistics
Market capUS$45.04b
Earnings (TTM)US$1.36b
Revenue (TTM)US$14.98b

33.4x

P/E Ratio

3.0x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
IQV income statement (TTM)
RevenueUS$14.98b
Cost of RevenueUS$9.75b
Gross ProfitUS$5.24b
Other ExpensesUS$3.88b
EarningsUS$1.36b

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)7.46
Gross Margin34.96%
Net Profit Margin9.06%
Debt/Equity Ratio224.5%

How did IQV perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.